cambridge healthtech institute catalog print_… · cambridge healthtech institute 250 first...

healthtech.comCambridge Healthtech Institute250 First Avenue, Suite 300 | Needham, MA 02494T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288 | F: (781) 972-5425

Cambridge Healthtech InstituteYour Life Science Network

Conference & Course CatalogAugust 2014 through February 2015

2 | Cambridge Healthtech Institute

For over 20 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.

Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.

For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.

About Cambridge Healthtech Institute

Follow us

TABLE OF CONTENTS

CONFERENCE SERIESBiological Therapeutic Products ...................................................... 4Biomarkers and Diagnostics ........................................................... 4Bioprocess and Manufacturing ....................................................... 5Clinical Trials & Translational Medicine ............................................ 5Chemistry ....................................................................................... 6BioPharmaceutical Strategy ............................................................ 6Drug Discovery & Development ..................................................... 6Drug Device & Safety ..................................................................... 7Drug Targets .................................................................................... 7Genomics ........................................................................................ 8Healthcare ....................................................................................... 8Informatics and IT ........................................................................... 8Therapeutic Indications ................................................................... 8Technology and Tools for Life Sciences ........................................... 9

CONFERENCES BY DATE WITH DETAIL ................................... 10-13

SHORT COURSE SCHEDULE .................................................... 14-15

CUSTOMER SERVICEPamela GerardiDirector of Customer ServiceE: [email protected] | T: 781-972-5409

Kris WatermanSr. Customer Service RepresentativeE: [email protected] | T: 781-972-5413

Rose LaRaiaCustomer Service RepresentativeE: [email protected] | T: 781-972-5400

MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441

Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456

SPONSOR & EXHIBIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467

Carol DinersteinDirector, Business DevelopmentE: [email protected] | T: 781-972-5471

GROUP SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472

GRAPHICSThomas NortonDesign DirectorE: [email protected] | T: 781-972-5440

PRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423

Christina LinghamExecutive Director of ConferencesE: [email protected] | T: 781-972-5464

Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497

Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139

Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709

CONTACT US

@CHI_Healthtech

linkedin.com/company/cambridge-healthtech-institute

youtube.com/user/cambridgehealthtech

Cambridge Healthtech Institute 250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288

F: (781) 972-5425

August 2014 - February 2015 Catalog | 3

KEY EVENTS

2015

2014

ONE STOP SHOP AFFILIATED REPORTSCOLLECTION

for Over 1,000 Life Science Reports Spanning over 50 Research AreasAn Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity …. Available through Insight Pharma Reports and our network of Affiliated Reports.

• Biomarkers: Neurobiomarkers and Neurodiagnostics

• Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks

• Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria

• Vaccines: The End of Illness

• MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics

• Ocular Disorders: Rising Therapeutics, Technologies, and Devices

• Prenatal Diagnostics: Invasive Testing, Noninvasive Testing, and Rising Maternal Screening Methods for Preeclampsia and Preterm Labor

For more information, contact Kerri Kelley at: [email protected] or call (781) 972-1347 InsightPharmaReports.com

Just some of the Reports Available Include:

• Alzheimer’s Disease• Biomarkers & Diagnostics• BioPharma Strategy• Biosimilars & Generic Markets• Cancer Research and

Therapeutics• Chemistry• Clinical Trials & Translational

• Medicine• Data Mining• Drug Discovery & Development• Health IT• Infectious Disease• Medical Devices• Multiple Sclerosis• Ocular• Pain Management• Pharmaceutical Marketing• Sequencing• Vaccines

...and many others

February 15-20, 2015Moscone North Convention CenterSan Francisco, CATriConference.com

May 4-8, 2015Seaport World Trade CenterBoston, MA

PEGSummit.com

The Protein Science Week

January 19-23, 2015Town and Country Resort and Convention CenterSan Diego, CACHI-PepTalk.com

June 10-12, 2015Westin Boston WaterfrontBoston, MA

WorldPharmaCongress.com

April 21-23, 2015Seaport World Trade CenterBoston, MA

Bio-ITWorldExpo.com

February 24-26, 2015Hyatt Regency OrlandoOrlando, FLSCOPESummit.com

April 21-23, 2015Hilton San Diego ResortSan Diego, CA

DrugDiscoveryChemistry.com

May 5-7, 2015Loews Philadelphia HotelPhiladelphia, PA

BiomarkerWorldCongress.com

BIOMARKERS & DIAGNOSTICS world congress

October 8-10, 2014Westin Boston WaterfrontBoston, MA

DiscoveryOnTarget.com

August 19-21, 2014Capital Hilton HotelWashington, DC

NextGenerationDx.com

August 18-22, 2014Renaissance Waterfront HotelBoston, MA

BioprocessingSummit.com

THE BIOPROCESSING SUMMIT


Conferences by Series

Biological Therapeutic Products

ImVacS: The Immunotherapies and Vaccine SummitAugust 11-14, 2014 • Boston, MA

Target Discovery for T Cell TherapyAugust 14, 2014 • Boston, MA

Rapid Methods to Assess Quality & Stability of BiologicsAugust 18-19, 2014 • Boston, MA

High-Concentration Protein FormulationsAugust 20-21, 2014 • Boston, MA

Early Analytical Development for BiotherapeuticsAugust 20-21, 2014 • Boston, MA

Process Development for Novel Biotherapeutic FormatsAugust 20-21, 2014 • Boston, MA

Antibodies Against Membrane Protein Targets - Part 1October 8-9, 2014 • Boston, MA

GPCR-Targeted TherapeuticsOctober 9-10, 2014 • Boston, MA


Clinical Biomarker Congress October 27-29, 2014 • La Jolla, CA

Targeting Key Antibacterial R&D ChallengesOctober 27-28, 2014 • Boston, MA

Protein Engineering EuropeNovember 3-7, 2014 • Lisbon, Portugal

Difficult to Express ProteinsNovember 3-4, 2014 • Lisbon, Portugal

Optimization & Development of BiologicsNovember 3-4, 2014 • Lisbon, Portugal

Phage and Yeast Display of AntibodiesNovember 3-4, 2014 • Lisbon, Portugal

Antibody Constructs and ScaffoldsNovember 5-6, 2014 • Lisbon, Portugal

Optimizing Protein ExpressionNovember 5-6, 2014 • Lisbon, Portugal

Protein Aggregates and ParticlesNovember 5-6, 2014 • Lisbon, Portugal

Antibody ExpressionNovember 6-7, 2014 • Lisbon, Portugal

Cancer BiotherapeuticsNovember 6-7, 2014 • Lisbon, Portugal

Analytical Characterization of BiotherapeuticsNovember 6-7, 2014 • Lisbon, Portugal

Immunogenicity and Bioassay Summit 2014November 17-19, 2014 • Bethesda, MD

PepTalk: The Protein Science WeekJanuary 19-23, 2015 • San Diego, CA

Optimizing Biologics Formulation DevelopmentJanuary 19-20, 2015 • San Diego, CA

Cancer Targets for Antibody TherapeuticsJanuary 19-20, 2015 • San Diego, CA

Recombinant Protein TherapeuticsJanuary 19-20, 2015 • San Diego, CA

Engineering Genes, Vectors, Constructs and ClonesJanuary 19-20, 2015 • San Diego, CA

Characterization of ADCs, Bispecifics and New BiotherapeuticsJanuary 19-20, 2015 • San Diego, CA

Single-Use Technologies and Continuous ProcessingJanuary 19-20, 2015 • San Diego, CA

Lyophilization and Emerging Drying TechnologiesJanuary 21-22, 2015 • San Diego, CA

Protein Purification and RecoveryJanuary 21-22, 2015 • San Diego, CA

Antibody-Drug ConjugatesJanuary 21-22, 2015 • San Diego, CA

Recombinant Protein Expression and ProductionJanuary 21-22, 2015 • San Diego, CA

Enhancing Antibody Binding and SpecificityJanuary 21-22, 2015 • San Diego, CA

Detection and Characterization of Particulates and ImpuritiesJanuary 21-22, 2015 • San Diego, CA

Membrane ProteinsJanuary 21-22, 2015 • San Diego, CA

High-Throughput Protein PurificationJanuary 22-23, 2015 • San Diego, CA

Protein Aggregation and Emerging Analytical ToolsJanuary 22-23, 2015 • San Diego, CA

Bispecific Antibody TherapeuticsJanuary 22-23, 2015 • San Diego, CA

Transient Protein ProductionJanuary 22-23, 2015 • San Diego, CA

Extractables and LeachablesJanuary 22-23, 2015 • San Diego, CA

Improving the Clinical Efficacy of Antibody TherapeuticsJanuary 22-23, 2015 • San Diego, CA

Next Generation Dx Summit August 19-21, 2014 • Washington, DC

Predictive Cancer BiomarkersAugust 19-20, 2014 • Washington, DC

Enabling Point-of-Care DiagnosticsAugust 19-20, 2014 • Washington, DC

Companion Diagnostics: Strategy & PartnershipsAugust 19-20, 2014 • Washington, DC

Inherited Disease DiagnosticsAugust 19-20, 2014 • Washington, DC

NGS-Based Assays in the Clinical SettingAugust 19-20, 2014 • Washington, DC

Molecular Diagnostics for Infectious DiseaseAugust 20-21, 2014 • Washington, DC

Companion Diagnostics: Technology & ReimbursementAugust 20-21, 2014 • Washington, DC



Continued

Commercialization of Molecular DiagnosticsAugust 20-21, 2014 • Washington, DC

Clinical Application of Cell-Free DNAAugust 20-21, 2014 • Washington, DC

Cancer Diagnosis at the Crossroads: Precision Medicine Driving ChangeSeptember 15-17, 2014 • Seattle, WA

Leaders in BioBanking CongressSeptember 15-17, 2014 • Seattle, WA

Digital PCR: Technologies and Tools for Precision DiagnosticsOctober 6-8, 2014 • La Jolla, CA

Cancer MetabolismOctober 9-10, 2014 • Boston, MA

Clinical Biomarker CongressOctober 27-29, 2014 • La Jolla, CA

Re-Entering Antibacterial Drug Development SummitOctober 27-29, 2014 • Boston, MA


POC and mHealth Diagnostics SummitNovember 5-7, 2014 • Boston, MA

Point-of-Care and Mobile Health Diagnostics TechnologiesNovember 5-6, 2014 • Boston, MA

Point-of-Care and Mobile Health Diagnostics Clinical-Consumer InterfaceNovember 6-7, 2014 • Boston, MA

Advances in Prenatal Molecular DiagnosticsNovember 5-7, 2014 • Boston, MA

Evidence-Based Reimbursement SummitNovember 17-19, 2014 • Bethesda, MD

Molecular DiagnosticsFebruary 15-18, 2015 • San Francisco, CA

Personalized DiagnosticsFebruary 15-18, 2015 • San Francisco, CA

Cancer Molecular MarkersFebruary 15-18, 2015 • San Francisco, CA

Circulating Tumor CellsFebruary 15-18, 2015 • San Francisco, CA

Digital PathologyFebruary 15-18, 2015 • San Francisco, CA

Companion DiagnosticsFebruary 15-18, 2015 • San Francisco, CA

PCR for Molecular MedicineFebruary 15-18, 2015 • San Francisco, CA

Genomic Sample Prep and Biospecimen ScienceFebruary 15-18, 2015 • San Francisco, CA

Epigenomics in DiseaseFebruary 15-18, 2015 • San Francisco, CA

Genome and Transcriptome AnalysisFebruary 15-18, 2015 • San Francisco, CA

Genomic Technologies for Patient StratificationFebruary 15-18, 2015 • San Francisco, CA

ImVacS: The Immunotherapies and Vaccine Summit August 11-14, 2014 • Boston, MA

The Bioprocessing SummitAugust 18-22, 2014 • Boston, MA

Optimizing Cell Culture TechnologyAugust 18-19, 2014 • Boston, MA

Overcoming Formulation Challenges for Biopharmaceutical DevelopmentAugust 18-19, 2014 • Boston, MA

Rapid Methods to Assess Quality & Stability of BiologicsAugust 18-19, 2014 • Boston, MA

CMC Strategies for Antibody-Drug ConjugatesAugust 18-19, 2014 • Boston, MA

High-Concentration Protein FormulationsAugust 20-21, 2014 • Boston, MA

Bioproduction: Scale, Bioreactors & DisposablesAugust 20-21, 2014 • Boston, MA

Process Development for Novel Biotherapeutic FormatsAugust 20-21, 2014 • Boston, MA

Higher-Order Protein StructureAugust 21-22, 2014 • Boston, MA

Optimizing Cell Line DevelopmentAugust 21-22, 2014 • Boston, MA

Advances in Purification TechnologiesAugust 21-22, 2014 • Boston, MA

Cell Therapy BioproductionAugust 21-22, 2014 • Boston, MA

Protein Engineering EuropeNovember 3-7, 2014 • Lisbon Portugal


Leaders in BioBanking Congress September 15-17, 2014 • Seattle, WA

GPCR-Based Drug Discovery October 8-9, 2014 • Boston, MA

Protein-Protein Interactions as Drug TargetsOctober 8-9, 2014 • Boston, MA





Solving the Antibacterials Commercialization EquationOctober 28-29, 2014 • Boston, MA

Strategic Resource ManagementNovember 3-4, 2014 • Philadelphia, PA

Portfolio ManagementNovember 4-5, 2014 • Philadelphia, PA

Immunogenicity and Bioassay Summit 2014November 17-19, 2014 • Bethesda, MD

Epigenomics in DiseaseFebruary 15-18, 2015 • San Francisco, CA



Continued

Translational to Clinical R&DFebruary 15-18, 2015 • San Francisco, CA

Clinical SequencingFebruary 15-18, 2015 • San Francisco, CA

Genomic Technologies for Patient StratificationFebruary 15-18, 2015 • San Francisco, CA

Technology-Driven Oncology Clinical DevelopmentFebruary 15-18, 2015 • San Francisco, CA

Summit for Clinical Ops Executives (SCOPE) February 24-26, 2015 • Orlando, FL

Electronic Data in Clinical TrialsFebruary 24-25, 2015 • Orlando, FL

Global Site Selection, Feasibility Assessment, Operations and Site ManagementFebruary 24-25, 2015 • Orlando, FL

Managing Late Stage Research, Observational Studies and RegistriesFebruary 24-25, 2015 • Orlando, FL

Enrollment Planning and Patient RecruitmentFebruary 24-25, 2015 • Orlando, FL

Clinical Trial Forecasting and BudgetingFebruary 24-25, 2015 • Orlando, FL

QbD and Risk Assessment for Clinical Trial ConductFebruary 24-25, 2015 • Orlando, FL

Integrating and Leveraging Clinical Trial Operations DataFebruary 25-26, 2015 • Orlando, FL

Clinical Trial Project Management for Outsourced Clinical TrialsFebruary 25-26, 2015 • Orlando, FL

Implementing Risk-Based MonitoringFebruary 25-26, 2015 • Orlando, FL

Improving Site-Study Activation and PerformanceFebruary 25-26, 2015 • Orlando, FL

Patient Engagement, Enrollment and Retention through Communities and TechnologyFebruary 25-26, 2015 • Orlando, FL

Boston Symposium on Organic and Bioorganic ChemistryOctober 8, 2014 • Boston, MA

Discovery on TargetOctober 8-10, 2014 • Boston, MA

Targeting the Ubiquitin Proteasome SystemOctober 8-9, 2014 • Boston, MA

GPCR-Based Drug DiscoveryOctober 8-9, 2014 • Boston, MA

Targeting Epigenetic Readers and Chromatin RemodelersOctober 8-9, 2014 • Boston, MA



Maximizing Efficiency in DiscoveryOctober 9-10, 2014 • Boston, MA


Targeting Histone Methyltransferases and DemethylasesOctober 9-10, 2014 • Boston, MA

Companion Diagnostics: Strategy & PartnershipsAugust 19-20, 2014 • Washington, DC

Companion Diagnostics: Technology & ReimbursementAugust 20-21, 2014 • Washington, DC

Commercialization of Molecular DiagnosticsAugust 20-21, 2014 • Washington, DC

Early Analytical Development for Biotherapeutics August 20-21, 2014 • Boston, MA



Strategic Resource ManagementNovember 3-4, 2014 • Philadelphia, PA

Portfolio ManagementNovember 4-5, 2014 • Philadelphia, PA

Evidence-Based Reimbursement SummitNovember 17-19, 2014 • Bethesda, MD


Immunomodulatory Therapeutic Antibodies for CancerAugust 11-12, 2014 • Boston, MA

Novel Vaccines-One: Adjuvants, TLRs & DNA VaccinesAugust 11-12, 2014 • Boston, MA

Combination Cancer ImmunotherapyAugust 12-13, 2014 • Boston, MA

Novel Vaccines-Part Two: Emerging Vaccine TechnologiesAugust 12-13, 2014 • Boston, MA

Target Discovery for T Cell TherapyAugust 14, 2014 • Boston, MA

Targeting Ocular DisordersOctober 6-7, 2014 • Boston, MA

Next-Generation Histone Deacetylase InhibitorsOctober 7, 2014 • Boston, MA



Continued



RNAi for Functional Genomics Screening - Part AOctober 8-9, 2014 • Boston, MA







Genome Editing for Functional Genomics Screens - Part BOctober 9-10, 2014 • Boston, MA




Screening Drug Transporter ProteinsOctober 9-10, 2014 • Boston, MA


Re-Entering Antibacterial Drug Development Summit October 27-29, 2014 • Boston, MA



Difficult to Express ProteinsNovember 3-4, 2014 • Lisbon, Portugal

Optimization & Development of BiologicsNovember 3-4, 2014 • Lisbon, Portugal

Phage and Yeast Display of AntibodiesNovember 3-4, 2014 • Lisbon, Portugal

Antibody Constructs and ScaffoldsNovember 5-6, 2014 • Lisbon, Portugal

Optimizing Protein ExpressionNovember 5-6, 2014 • Lisbon, Portugal

Protein Aggregates and ParticlesNovember 5-6, 2014 • Lisbon, Portugal

Antibody ExpressionNovember 6-7, 2014 • Lisbon, Portugal

Cancer BiotherapeuticsNovember 6-7, 2014 • Lisbon, Portugal

Analytical Characterization of BiotherapeuticsNovember 6-7, 2014 • Lisbon, Portugal

FAST: Functional Analysis & Screening Technologies CongressNovember 17-19, 2014 • Boston, MA

Engineering Functional 3D ModelsNovember 17-18, 2014 • Boston, MA

Phenotypic Drug DiscoveryNovember 17-19, 2014 • Boston, MA

Organotypic Culture Models for ToxicologyNovember 17-18, 2014 • Boston, MA

Screening and Functional Analysis of 3D ModelsNovember 18-19, 2014 • Boston, MA

Physiologically-Relevant Cellular Tumor Models for Drug DiscoveryNovember 18-19, 2014 • Boston, MA

Drug & DeviceSafety Series


Extractables and LeachablesJanuary 22-23, 2015 • San Diego, CA

Drug TargetsSERIES

Target Discovery for T Cell Therapy August 14, 2014 • Boston, MA

Single-Cell SequencingAugust 20-21, 2014 • Washington, DC





Big Data Analytics and SolutionsOctober 8-9, 2014 • Boston, MA








Continued













Single-Cell Sequencing August 20-21, 2014 • Washington, DC










Managing Late Stage Research, Observational Studies and RegistriesFebruary 24-25, 2015 • Orlando, FL

Pharmacovigilance and Adverse Events ReportingFebruary 25-26, 2015 • Orlando, FL

Single-Cell Sequencing August 20-21, 2014 • Washington, DC



Bioinformatics for Big DataFebruary 15-18, 2015 • San Francisco, CA

Integrated Pharma Informatics & Data ScienceFebruary 15-18, 2015 • San Francisco, CA

Genome and Transcriptome AnalysisFebruary 15-18, 2015 • San Francisco, CA

Summit for Clinical Ops Executives (SCOPE)February 24-26, 2015 • Orlando, FL

Electronic Data in Clinical TrialsFebruary 24-25, 2015 • Orlando, FL

Integrating and Leveraging Clinical Trial Operations DataFebruary 25-26, 2015 • Orlando, FL

Patient Engagement, Enrollment and Retention through Communities and TechnologyFebruary 25-26, 2015 • Orlando, FL

SERIESCancer Diagnosis at the Crossroads: Precision Medicine Driving Change September 15-17, 2014 • Seattle, WA





Continued











Targeting Tick-Borne DiseasesOctober 29-30, 2014 • Boston, MA


Cancer Targets for Antibody TherapeuticsJanuary 19-20, 2015 • San Diego, CA

Circulating Tumor CellsFebruary 15-18, 2015 • San Francisco, CA

Predictive Preclinical Models in OncologyFebruary 15-18, 2015 • San Francisco, CA

Cancer Molecular MarkersFebruary 15-18, 2015 • San Francisco, CA

Translational to Clinical R&DFebruary 15-18, 2015 • San Francisco, CA

Technology-Driven Oncology Clinical DevelopmentFebruary 15-18, 2015 • San Francisco, CA

Enabling Point-of-Care DiagnosticsAugust 19-20, 2014 • Washington, DC

NGS-Based Assays in the Clinical SettingAugust 19-20, 2014 • Washington, DC

Clinical Application of Cell-Free DNAAugust 20-21, 2014 • Washington, DC

Single-Cell SequencingAugust 20-21, 2014 • Washington, DC
















Point-of-Care and Mobile Health Diagnostics TechnologiesNovember 5-6, 2014 • Boston, MA







Engineering Genes, Vectors, Constructs and ClonesJanuary 19-20, 2015 • San Diego, CA

Characterization of ADCs, Bispecifics and New BiotherapeuticsJanuary 19-20, 2015 • San Diego, CA

Lyophilization and Emerging Drying TechnologiesJanuary 21-22, 2015 • San Diego, CA

Recombinant Protein Expression and ProductionJanuary 21-22, 2015 • San Diego, CA

Detection and Characterization of Particulates and ImpuritiesJanuary 21-22, 2015 • San Diego, CA

Membrane ProteinsJanuary 21-22, 2015 • San Diego, CA

Transient Protein ProductionJanuary 22-23, 2015 • San Diego, CA



ImVacS, The Immunotherapies and Vaccine Summit, brings together a global audience of vaccine researchers and developers of cancer immunotherapies for five focused meetings that explore the frontiers of immunology as the basis for patient treatment. 250+ researchers from around the world gather to discuss new data, new approaches and novel science from industry, academia, regulatory, and research institutes in a collegial atmosphere that encourages interaction and information sharing.

ImVacS.com

The Bioprocessing Summit August 18-22, 2014 • Boston, MA

The Bioprocessing Summit brings together international leaders to discuss today’s bioprocess issues from cell line selection to bioproduction. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking.

This leading bioprocess meeting is hosted in Boston each summer along the lively and cosmopolitan harbor waterfront. Hundreds of bioprocess professionals come together each year at the Summit to share practical solutions for today’s laboratory challenges with researchers from around the world.

BioprocessingSummit.com

Next Generation Dx Summit August 19-21, 2014 • Washington, DC

Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell free DNA and single cell sequencing.

This event has become the meeting place for major players in the expanding arena of diagnostics. It will showcase key components of their successful adoption in the clinic and advancement to the market. Please join the leaders in the community for another exceptional year.

NextGenerationDx.com

Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change September 15-17, 2014 • Seattle, WA

Tumor collections provide insight into the great variability of cancer, its progression and its response to treatment. Patient xenografts and cell models (PDX) allow researchers to link and integrate information and determine personal variations in cancer molecular profiles. The recent advancements in high-throughput genomics, proteomics and other -omics platforms allow profiling of large numbers of cancer analytes in a single assay. Thus, knowledge of these altered molecular landscapes offers great promise for developing molecular tests to improve cancer diagnosis and optimize treatment.

Cambridge Healthtech Institute’s Inaugural Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change convenes international oncology experts in the fields of tumor biospecimen research, PDX models, molecular diagnostics/prognostics and pharmacogenomics.

Healthtech.com/Precision-Medicine-Cancer

Leaders in BioBanking Congress September 15-17, 2014 • Seattle, WA

Today, biospecimen collections are used by multiple research groups for varying research aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. The proper collection, processing, storage and tracking of biospecimens are critical components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. Cambridge Healthtech Institute’s Sixth Annual Leaders in Biobanking Congress: Maximizing Your Investment in Biospecimens addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cuttingedge research.

Healthtech.com/Biobanking

Digital PCR: Technologies and Tools for Precision Diagnostics October 6-8, 2014 • La Jolla, CA

Digital PCR’s ability to precisely quantitate, identify mutations and copy number variations, and to perform gene expression analysis is creating waves across the diagnostics landscape. It is well suited for single-cell analysis and shows promise to become a superior tool in the clinic due to its capacity to work with small amounts of sample. The Third Annual Digital PCR event will bring together industry visionaries and early adopters to discuss digital PCR’s capabilities, limitations, and future applications. Researchers will examine applications in cancer biomarker and rare mutation detection, non-invasive fetal DNA analysis, and infectious disease quantification, particularly in HIV. Novel digital PCR devices from startups and academic labs will be showcased. Other topics to be addressed include digital PCR integration with existing technologies, solutions for processing difficult samples as well as increasing sample throughput, and guidelines and best practices for digital detection.

Healthtech.com/Digital-PCR

Targeting Ocular Disorders October 6-7, 2014 • Boston, MA

With the aging of the population, the need for treatments of ocular diseases and disorders has become more important than ever. Increasingly high incidences of age-related macular degeneration (AMD), glaucoma, diabetic retinopathy and ocular inflammatory diseases demand better, more effective and innovative treatments. If we are to maintain the quality of life for this aging population, the preservation of vision is critical. This conference will address targeting of ophthalmic medications and treatments and will provide the latest results in the field, along with novel and emerging targets that hold promise in treating these quality of life threats.

Healthtech.com/Targeting-Ocular-Disorders

Conferences by Date with Detail


Boston Symposium on Organic and Bioorganic ChemistryOctober 8, 2014 • Boston, MA

Pfizer, Merck and Amgen are proud to present the Third Annual Boston Symposium on Organic and Bioorganic Chemistry, which will be held October 8, 2014, at the Merck Research Laboratories Boston facility. This unique forum brings together Boston area students and leading academic and industry scientists, and will provide an experience for attendees that includes:

• Keynote presentations showcasing cutting edge science from Professor James Morken (Boston College) and a drug discovery case study from Pfizer.

• Oral and poster presentations by students and professional scientists from world-class Boston area academic and industrial institutions.

• Extensive networking opportunities for students, faculty, and industry scientists.

BSOBC.net

Discovery on Target October 8-10, 2014 • Boston, MA

Cambridge Healthtech Institute will host its 12th Annual Discovery on Target event showcasing current and emerging “hot” targets for the pharmaceutical industry, October 8-10, 2014 in Boston, MA. Spanning three days, the meeting attracts over 900+ attendees (from 24 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2014 the event is comprised of 14 conference tracks which include Epigenetic Readers, Ubiquitin Proteasome, Big Data Discovery, GPCR Drug Discovery, RNAi-Screens-Functional-Genomics, PPI Targets, Protein-Targets, Histone-Methyltransferases-Demethylases, Drug Transporters, Maximizing Efficiency, GPCR Therapeutics, Genomics Screening, Cancer Metabolism and Membrane Production. The 2014 event will offer 200+ scientific presentations across 14 conference tracks, 1 Symposium and 15 conference short courses, 40+ interactive breakout discussion groups, an exhibit hall of 40+ companies, and dedicated poster viewing and networking sessions. The 12th Annual Discovery on Target assembles an impressive group of 195+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.

DiscoveryOnTarget.com

Clinical Biomarker Congress October 27-29, 2014 • La Jolla, CA

The recent growth in complex biological data, driven by improvements in NGS and mutation analysis technologies, promises to enable the paradigm shift toward precision medicine. Cambridge Healthtech Institute’s Sixth Annual Clinical Biomarker Congress (October 27-29, 2014, in La Jolla, CA) will bring together thought leaders from large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers to discuss the latest advances in biomarker applications in drug development, including biomarker utility in translational medicine and clinical trials, utility of NGS and mutation analysis tools for patient stratification biomarkers, strategies to co-develop drugs with companion diagnostics, advances in assay development for clinical biomarkers, and strategies to tackle “big data”

challenges for the advancement of personalized medicine and biomarker discovery. Please join us in La Jolla for comprehensive scientific coverage and unparalleled networking opportunities at the Clinical Biomarker Congress, the West Coast event in CHI’s signature Biomarker Series.

ClinicalBiomarkerCongress.com

Re-Entering Antibacterial Drug Development Summit October 27-29, 2014 • Boston, MA

Several factors including diminishing financial return, lack of new discovery platforms and others, had a cooling effect on pharmaceutical companies’ activity in the area of antibacterial drug development. At the same time, we are witnessing the wide spread of resistant bacteria, leading to untreatable infections. “We are facing a huge crisis worldwide not having an antibiotics pipeline,” said Dr. Janet Woodcock, Director of CDER at FDA, in her recent interview to NYT. The governments of European countries and the United States have created several incentives for the industry to rise to the challenge. Therefore, many companies are exploring the opportunities to start or re-open their antibacterial departments, or to stimulate the existing research and development. Cambridge Healthtech Institute is pleased to present its inaugural Re-Entering Antibacterial Drug Development Summit that includes a science track and a business track, and features a wide range of pivotal issues. The Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders shaping the current state of antibacterial discovery and development.

Healthtech.com/Antibacterial-Drug-Development

Targeting Tick-Borne Diseases October 29-30, 2014 • Boston, MA

The rapid expansion of tick-borne illness in the Americas and Europe poses great challenges for the prevention and treatment of these diseases, in both humans and animals. Though Lyme Disease continues to be the predominant disease (with estimates of as many as 300,000 new cases every year in the US), new and emerging illnesses are increasingly reported. The cost for treatment of these diseases continues to rise. As humans and animals spend more time in wooded areas, the threat becomes even more urgent. This conference will address the newest science in the pathogenesis of these diseases, along with the latest research into prevention and treatment of these crippling illnesses.

Healthtech.com/Targeting-Tick-Borne-Diseases

PEGS Europe November 3-7, 2014 • Lisbon Portugal

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. With two consecutive years of 40% growth in attendance, and another year of expanded program coverage, this year’s event will feature:

• 500 attendees• 150 technical presentations• 70+ scientific posters• 40+ sponsors & exhibitors• Dedicated networking opportunities• Exclusive exhibit & poster hours• Interactive roundtable, breakout & panel discussions

PEGSummitEurope.com



Executive Decision MakingNovember 3-5, 2014 • Philadelphia, PA

Cambridge Healthtech Institute’s 12th Annual “Strategic Resource Management” and 9th Annual “Portfolio Management” will be held November 3-5, 2014 in Philadelphia, PA at the Hyatt Penn’s Landing. It is the leading biopharma executive decision making forum for those who help lead their organizations’ resource management, portfolio management, innovation, decision analysis, R&D, forecasting and corporate strategies.

ExecutiveDecisionMaking.com

POC and mHealth Diagnostics Summit November 5-7, 2014 • Boston, MA

The growth and proliferation of point-of-care testing and mobile health devices is an indicator of the transformation in the IVD market, driven by the need to reduce the cost of healthcare and shorten the time required to get test results. A newly emerging DTC segment will meet the needs of consumers who are willing to pay out of pocket to manage their own health information by creating an array of tools designed to enable preventative medicine. This inaugural event will highlight advances in the rapid testing market in two sections: the development of technologies and the progression to the clinical and consumer interface.

Healthtech.com/POC-mHealth-Diagnostics-Summit

Advances in Prenatal Molecular Diagnostics November 5-7, 2014 • Boston, MA

The field of prenatal diagnostics is undergoing rapid and significant change, as a variety of molecular diagnostics are transforming the type and quality of data that can be provided to pregnant women and their physicians. Array-based cytogenetic analysis can provide more detailed and accurate assessment of many genetic conditions compared with traditional karyotyping, both of which rely on samples obtained using invasive procedures. Since obtaining samples invasively, even in the most proficient hands, does involve some risk to the fetus, there has been tremendous interest in non-invasive testing approaches. Next-gen sequencing of cell-free DNA found in maternal blood has been demonstrated to provide highly accurate assessment of fetal aneuploidies, with quite low false positives and false negatives, in most cases. Best practice guidelines have been modified quite quickly to recommend that such testing be offered to women who are at increased risk of aneuploidies, either because of past history, advanced maternal age or other reasons, and adoption and agreement by insurers to cover such testing has occurred at unprecedented speed. Such tests are not without controversy, however, because they only test for the most common chromosome duplications, and are unable thus far to provide analysis of smaller genetic insertions, deletions and rearrangements. One alternative approach has been research on obtaining circulating fetal cells from maternal blood, which would offer the advantages of being non-invasive, and isolated from confounding maternal DNA, but the challenges of reliably obtaining such rare cells has delayed the prospects for commercialization. This conference will provide an in-depth examination of key issues, technical and practical developments in these areas, and opportunities for discussing some of the issues that will have an impact on how this field continues to quickly evolve in the near future.

Healthtech.com/Prenatal-Diagnostics


CHI is proud to announce the 2nd Annual FAST: Functional Analysis & Screening Technologies Congress to be held on November 17-19, 2014 in Boston, MA. Join our community of 250+ engineers, biologists, screening managers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery.

FASTCongress.com

Evidence-Based Reimbursement Summit November 17-19, 2014 • Bethesda, MD

Stratified genomic medicine, genome-guided prevention and treatment of complex diseases, is becoming a reality due to the latest achievements in genome research as well as the clinical implementation of powerful technologies such as massively parallel sequencing and digital PCR. The bottleneck of this innovation coming into clinical practice is the current reimbursement uncertainty. The combination of tightening health care budgets and the launch of a large number of expensive molecular tests as well as pricey targeted therapies creates complications for payers to respond in traditional ways. The Third Annual Evidence-Based Reimbursement Summit is designed to bring together major stakeholders from pharmaceutical, biotech, IVD companies, laboratory medicine community and healthcare providers community to exchange opinions and to search for solutions in the innovative medicine commercialization equation.

Healthtech.com/Evidence-Based-Reimbursement-Summit

Immunogenicity and Bioassay Summit 2014 November 17-19, 2014 • Bethesda, MD

Following year-on-year success, CHI presents the Sixth Annual Immunogenicity and Bioassay Summit 2014: 3 conferences, 45+ presentations, 15+ interactive breakout round table and panel discussions, exhibit/poster hall, and networking opportunities. Immunogenicity Prediction & Mitigation is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of bioassays and immunoassays and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements. Browse through this website to view preliminary details. Register today so you can join 250+ of your peers at the Number 1 Immunogenicity Summit in the U.S.

ImmunogenicitySummit.com



PepTalk: The Protein Science Week January 19-23, 2015 • San Diego, CA

PepTalk: The Protein Science Week is one of the largest gatherings of protein science researchers in the United States, and when you bring together some of the most influential people in the field - big things happen! PepTalk offers an array of education, innovation and networking programs. Over 300 high-caliber speakers share case studies, unpublished data, breakthroughs and solutions that support and enhance your research. Ample networking opportunities allow you to connect with colleagues and peers from around the world and gain new perspectives on the evolution of biologics.

Choose between 19 Conferences, 12 Short Courses, 3 Training Seminars, 90+ BuzZ Session Discussion Roundtables, and dedicated exhibit hall and poster viewing hours to create a custom agenda that fits your research and networking needs!

CHI-PepTalk.com

Molecular Medicine Tri-ConferenceFebruary 15-20, 2015 • San Francisco, CA

The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.

For over 20 years, Tri-Conference attendees gained insight and knowledge by attending the event, knowledge that they were able to take with them, and have an immediate impact on their research. Plan to attend this year’s event where you can be part of driving change and working towards shaping the future of medicine.

TriConference.com

Summit for Clinical Ops Executives (SCOPE)February 24-26, 2015 • Orlando, FL

The 6th Annual SCOPE Summit, taking place February 24-26, 2015 in Orlando, FL, will offer three stimulating days of in-depth discussions in 12 different conferences focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Forecasting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, and Pharmacovigilance.

SCOPESummit.com


250 First Avenue, Suite 300 Needham, MA 02494 www.healthtech.com l T 781-972-5440 l F 781-972-5425

Your Life Science NetworkCambridge Healthtech Institute

healthtech.com/medialibrary

LIFE SCIENCE

MEDIALIBRARY

Continue Your Education with CHI’s Digital Courses

Navigate, pause, rewind and listen to recorded sessions in a multimedia presentation. Visit CHI’s Life Science Media Library to view over 120 digital courses recorded at our most successful events.

Formats available: Digital Download | On Demand | DVD

Healthtech.com/MediaLibraryOrder Today


Short Course Title Conference / Date / LocationIMVACS: THE IMMUNOTHERAPIES AND VACCINE SUMMIT

Vaccine Production & Manufacturing August 12, 2014 • Boston, MA

Cancer Vaccines: Clinical Updates, New Technologies and Challenges August 12, 2014 • Boston, MA

THE BIOPROCESSING SUMMIT

Optimizing Media-Achieving Super Soup August 18, 2014 • Boston, MA

QbD Strategies for Formulation Development of Protein Therapeutics August 18, 2014 • Boston, MA

Operational Excellence in Bioprocessing: PAT, QbD, DoE and Continuous Improvement August 18, 2014 • Boston, MA

ADC “Developability”: Critical Quality Attributes Inform Formulation August 18, 2014 • Boston, MA

Extractables & Leachables August 19, 2014 • Boston, MA

Accelerated Stability Testing of Biologics August 19, 2014 • Boston, MA

Analytical Strategies for Comparability in Bioprocess Development August 19, 2014 • Boston, MA

Biophysical Characterization in Developing Biopharmaceuticals August 21, 2014 • Boston, MA

ABC: Anything But Chromatography-Precipitation, Crystallization and Flocculation August 21, 2014 • Boston, MA

Bioprocess Development: Considerations for the Quality and Safety of Materials in Contact with Biologics

August 21, 2014 • Boston, MA

NEXT GENERATION DX SUMMIT

Overcoming Challenges of Working with FFPE Samples August 18, 2014 • Washington, DC

NGS Data Analysis-Determing Clinical Utility of Genome Variants August 18, 2014 • Washington, DC

Microfluidics for Point-of-Care : Technologies, Applications and Products August 18, 2014 • Washington, DC

Next Generation Sequencing as a Diagnostics Platform August 18, 2014 • Washington, DC

Clinical Trials to Establish Value of Diagnostic Tests: Design & Management August 18, 2014 • Washington, DC

Use of CLIA-Waived Point-of-Care and Rapid Dianostic Tests in Community Pharmacies August 18, 2014 • Washington, DC

Regulatory Compliance in Drug-Diagnostics Co-Development August 18, 2014 • Washington, DC

Leading Product Innovation August 18, 2014 • Washington, DC

Sample Prep Methods for Liquid Biopsy and POC Molecular Diagnostics August 18, 2014 • Washington, DC

Regulatory and Reimbursement Issues with Next-Generation Sequencing and Multiplex Assays August 20, 2014 • Washington, DC

NGS for Infectious Disease Diagnostics August 20, 2014 • Washington, DC

CANCER DIAGNOSIS AT THE CROSSROADS: PRECISION MEDICINE DRIVING CHANGE

Advances in Patient-Derived Xenograft (PDX) Models September 14, 2014 • Seattle, WA

LEADERS IN BIOBANKING CONGRESS

Biobanking is More than Sample Storage and Management September 14, 2014 • Seattle, WA

Short Course Schedule HOLD A COURSE AT YOUR FACILITY.For more information, please contact Edel O’Regan at 781-972-5423 or email: [email protected]


Short Course Title Conference / Date / LocationWhat It Takes to Be a Biobanking Operations Manager September 16, 2014 • Seattle, WA

DIGITAL PCR

Digital PCR Experiment Design and Primer October 6, 2014 • La Jolla, CA

Single-Cell Genomic Analysis October 7, 2014 • La Jolla, CA

DISCOVERY ON TARGET

Designing Scalable Software Systems for Big Data Analytics October 7, 2014 • Boston, MA

Approaches for Biologically-Relevant Chemical Diversity October 7, 2014 • Boston, MA

Setting Up Effective RNAi Screens: From Design to Data to Validation October 7, 2014 • Boston, MA

Targeting Protein-Protein Interactions October 7, 2014 • Boston, MA

GPCR Structure-Based Drug Discovery October 7, 2014 • Boston, MA

Advances in Metagenomic Drug Discovery for New Anti-Infective Agents October 7, 2014 • Boston, MA

Targeting of GPCRs with Monoclonal Antibodies October 7, 2014 • Boston, MA

A Primer to Gene Editing: Tools and Applications October 7, 2014 • Boston, MA

Introduction to Targeted Covalent Inhibitors October 7, 2014 • Boston, MA

Next-Generation Histone Deacetylase Inhibitors Symposium October 7, 2014 • Boston, MA

Integration of BDDCS and Extended Clearance Principles October 9, 2014 • Boston, MA

Setting Up Effective Functional Screens Using 3D Cell Cultures October 9, 2014 • Boston, MA

Introduction to Allosteric Modulators and Biased Ligands of GPCRs October 9, 2014 • Boston, MA

Introduction to Drug Metabolism October 9, 2014 • Boston, MA

PORTFOLIO MANAGEMENT

Project Portfolio Management Certification Master Class November 4, 2014 • Philadelphia, PA

POC + MHEALTH DIAGNOSTICS

Commercialization Boot Camp: Manual for Success in Diagnostics November 4, 2014 • Boston, MA

Technologies and Applications for Point-of-Care Testing for Infectious Disease November 4, 2014 • Boston, MA

The Future of PoC and DTC: Why New Strategies are Necessary for Larger Markets November 6, 2014 • Boston, MA

IMMUNOGENICITY AND BIOASSAY SUMMIT

Basics of Immunogenicity Testing for Innovators and Biosimilars November 16, 2014 • Bethesda, MD

Challenges of Immunogenicity Assessment for Innovators and Biosimilars November 16, 2014 • Bethesda, MD

Immunogenicity Risk Assessment & Regulatory Strategy November 18, 2014 • Bethesda, MD

Maintenance and Controlling Assay Performance November 18, 2014 • Bethesda, MD

Short Course Schedule

August 2014 - February 2015 Catalog | 16 healthtech.com

Cambridge Healthtech Institute250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288 | F: (781) 972-5425

Your Life Science NetworkCambridge Healthtech Institute

cambridge healthtech institute catalog print_… · cambridge healthtech institute 250 first...

Documents